Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
Open | $8.580 |
Close | $8.650 |
Volume / Avg. | 38.547K / 778.372K |
Day Range | 8.280 - 8.710 |
52 Wk Range | 3.190 - 14.300 |
Market Cap | $267.073M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 8.77% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acrivon Therapeutics (NASDAQ: ACRV) through any online brokerage.
Other companies in Acrivon Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP), Monte Rosa Therapeutics (NASDAQ:GLUE) and Century Therapeutics (NASDAQ:IPSC).
The latest price target for Acrivon Therapeutics (NASDAQ: ACRV) was reported by BMO Capital on Wednesday, May 15, 2024. The analyst firm set a price target for 25.00 expecting ACRV to rise to within 12 months (a possible 189.02% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $8.65 last updated May 15, 2024 at 4:25 PM EDT.
There are no upcoming dividends for Acrivon Therapeutics.
Acrivon Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Acrivon Therapeutics.
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.